Memantine 10 mg (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Huons Lifescience Co., Ltd.
MFDS item code 201504334 · Approved 2015.07.01
This product's status changed to Approval withdrawn on 2024.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically confirm that the patient is taking the medicine. Diagnosis should be made according to currently accepted guidelines. Periodically reassess the clinical benefit of this medicine and the patient's tolerability of treatment. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7): Administer 5mg daily for 7 days. Week 2 (days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This drug should not be used by patients who are allergic to any of its components, have very poor liver function, or have severely impaired kidney function. Additionally, since this medication contains lactose, it should not be administered to patients with genetic disorders related to lactose intolerance. Patients with epilepsy or those who have experienced seizures, or those at high risk of developing epilepsy should use this medication cautiously. It is important not to take this medication with specific drugs such as amantadine, ketamine, and dextromethorphan, as this may increase central nervous system side effects. Precautions should be taken in patients with changes in urinary acidity or those who have had recent heart disease. During treatment with this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; if symptoms are severe, consult a physician. Interactions with other drugs may occur, so it is essential to inform your doctor about any current medications, especially when combining with anticoagulants or muscle relaxants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication and are advised to stop breastfeeding if nursing. It is preferable not to use this medication in children or adolescents under 18 years of age as the safety and effectiveness have not been verified. Overdose may result in central nervous system symptoms or gastrointestinal symptoms, and in suspected cases, immediate medical attention should be sought. This medication may affect patients' response times, so caution should be exercised when driving or operating machinery. Finally, this medication should be kept out of the reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help preserve the effectiveness of the medication for a long time.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Huons Lifescience Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.